Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tesetaxel in previously treated metastatic urothelial carcinoma
NCT01215877Phase 2Unknown
- Sponsor
- Genta Incorporated
- Start
- Sep 2010
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of tesetaxel in transitional cell carcinoma (TCC), sponsored by Genta Incorporated. Status: unknown.
02
Drugs
tesetaxel
03
Conditions
transitional cell carcinoma (TCC)
Beyond the preview
Go deeper on NCT01215877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01215877.